Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases

被引:29
作者
Brettschneider, Johannes [9 ]
Jaskowski, Troy D. [8 ]
Tumani, Hayrettin [9 ]
Abdul, Sana [9 ]
Husebye, Dee [7 ]
Seraj, Haniah [7 ]
Hill, Harry R. [4 ,5 ,6 ]
Fire, Ella [3 ]
Spector, Larissa [3 ]
Yarden, Jennifer [3 ]
Dotan, Nir [3 ]
Rose, John W. [1 ,2 ]
机构
[1] Univ Utah, Neurovirol Res Lab, VASLCHCS, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA
[3] Glycominds Ltd, Lod, Israel
[4] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA
[5] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA
[6] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA
[7] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA
[8] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA
[9] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany
关键词
Relapsing remitting multiple sclerosis; Primary progressive multiple sclerosis; Diagnosis; Anti-glucose antibodies; Serum; Enzyme immunoassay; CLINICALLY ISOLATED SYNDROMES; 1ST DEMYELINATING EVENT; DIAGNOSTIC-CRITERIA; ANTIMYELIN ANTIBODIES; MCDONALD CRITERIA; BIOMARKERS; MARKER; MRI; AUTOANTIBODIES; DISABILITY;
D O I
10.1016/j.jneuroim.2009.07.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
The serum level of IgM antibodies against Glc(alpha 1,4)Glc(alpha) (GAGA4) is higher in relapsing remitting multiple sclerosis (RRMS) compared to other neurological disease (OND) patients and healthy controls (HQ. Detecting the level of anti-GAGA4 antibody by enzyme immunoassay and total IgM, we confirmed that anti-GAGA4 IgM can differentiate RRMS from OND patients and HC Moreover, secondary progressive MS (SPMS) and RRMS patients have similar levels of anti-GAGA4 demonstrating the biomarker's presence throughout the disease. Interestingly, the anti-GAGA4 assay may also differentiate between primary progressive MS (PPMS) and RRMS/SPMS patients, since nearly all PPMS patients were negative for the assay. (C) 2009 Published by Elsevier B.V.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 34 条
[1]
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [J].
Berger, T ;
Rubner, P ;
Schautzer, F ;
Egg, R ;
Ulmer, H ;
Mayringer, I ;
Dilitz, E ;
Deisenhammer, F ;
Reindl, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :139-145
[2]
Multiple sclerosis: Disease biomarkers as indicated by pathophysiology [J].
Berger, Thomas ;
Reindl, Markus .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 259 (1-2) :21-26
[3]
Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis:: Implications for multiple sclerosis [J].
Boullerne, AI ;
Rodríguez, JJ ;
Touil, T ;
Brochet, B ;
Schmidt, S ;
Abrous, ND ;
Le Moal, M ;
Pua, JR ;
Jensen, MA ;
Mayo, W ;
Arnason, BGW ;
Petry, KG .
JOURNAL OF NEUROSCIENCE, 2002, 22 (01) :123-132
[4]
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis [J].
Brex, PA ;
Ciccarelli, O ;
O'Riordan, JI ;
Sailer, M ;
Thompson, AJ ;
Miller, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) :158-164
[5]
The differential diagnosis of Axis I psychopathology presenting to a university-based multiple sclerosis clinic [J].
Brousseau, K. M. ;
Arciniegas, D. B. ;
Carmosino, M. J. ;
Corboy, J. R. .
MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (06) :749-753
[6]
Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis [J].
Dalton, CM ;
Brex, PA ;
Miszkiel, KA ;
Hickman, SJ ;
MacManus, DG ;
Plant, GT ;
Thompson, AJ ;
Miller, DH .
ANNALS OF NEUROLOGY, 2002, 52 (01) :47-53
[7]
Prognosis of the individual course of disease - steps in developing a decision support tool for Multiple Sclerosis [J].
Daumer, M. ;
Neuhaus, A. ;
Lederer, C. ;
Scholz, M. ;
Wolinsky, J. S. ;
Heiderhoff, M. .
BMC MEDICAL INFORMATICS AND DECISION MAKING, 2007, 7 (1)
[8]
Role of B-1a cells in autoimmunity [J].
Duan, Byian ;
Morel, Laurence .
AUTOIMMUNITY REVIEWS, 2006, 5 (06) :403-408
[9]
Differential diagnosis of multiple sclerosis [J].
Fadil, Halim ;
Kelley, Roger E. ;
Gonzalez-Toledo, Eduardo .
NEUROBIOLOGY OF MULTIPLE SCLEROSIS, 2007, 79 :393-422
[10]
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis [J].
Fisniku, L. K. ;
Brex, P. A. ;
Altmann, D. R. ;
Miszkiel, K. A. ;
Benton, C. E. ;
Lanyon, R. ;
Thompson, A. J. ;
Miller, D. H. .
BRAIN, 2008, 131 :808-817